Quick Takeaways
- This page summarizes Isaac Manke's Form 4 filing for OnKure Therapeutics, Inc. (OKUR).
- 1 reported transaction and 1 derivative row are listed below.
- Filing timestamp: 08 Oct 2024, 19:27.
Isaac Manke - 04 Oct 2024 Form 4 Insider Report for OnKure Therapeutics, Inc. (OKUR)
- Role
- Director
- Signature
- /s/ Rogan Nunn, by power of attorney
- Issuer symbol
- OKUR
- Transactions as of
- 04 Oct 2024
- Net transactions value
- $0
- Form type
- 4
- Filing time
- 08 Oct 2024, 19:27:36 UTC
- Previous filing
- 30 Sep 2024
- Next filing
- 27 Feb 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Isaac Manke filed Form 4 for OnKure Therapeutics, Inc. (OKUR) on 08 Oct 2024."
What Changed
- Previous filing in this sequence was filed on 30 Sep 2024.
- Current net transaction value: $0.
Why This Matters
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Official SEC Source
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | OKUR | Stock Option (right to buy) | Award | $0 | +15,300 | $0.000000 | 15,300 | 04 Oct 2024 | Class A Common Stock | 15,300 | $18.20 | Direct | F1 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | 1/36th of the shares subject to the option shall vest on November 4, 2024 and each month thereafter, subject to the Reporting Person continuing as a service provider through each such date. |